Get the Stockscreener App
7.78
2.51%
-0.20
After Hours:
7.77
-0.01
-0.13%
Rxsight Inc stock is traded at $7.78, with a volume of 734.47K.
It is down -2.51% in the last 24 hours and down -40.15% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$7.98
Open:
$7.86
24h Volume:
734.47K
Relative Volume:
0.58
Market Cap:
$316.16M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-9.4878
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-2.02%
1M Performance:
-40.15%
6M Performance:
-77.03%
1Y Performance:
-83.00%
1-Day Range:
$7.64
$7.91
1-Week Range:
$7.64
$8.31
52-Week Range:
$6.32
$58.23
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.78 | 324.28M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - TradingView
Levi & Korsinsky Reminds RxSight, Inc. Investors of the - GlobeNewswire
Faruqi & Faruqi Reminds RxSight Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025RXST - ACCESS Newswire
Shareholders who lost money on their RxSight, Inc. (NASDAQ: - GlobeNewswire
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
RxSight Faces an Investors Lawsuit Over Growth Claims—Here’s What You Should Know - TradingView
Shareholders That Lost Money on RxSight, Inc. (RXST) Should Contact Levi & Korsinsky About Pending Class ActionRXST - The Globe and Mail
Investors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - MarketScreener
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
RXST INVESTORS: RxSight, Inc. (NASDAQ:RXST) Investors may - GlobeNewswire
RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, - GlobeNewswire
CLASS ACTION NOTICE: Berger Montague Advises RxSight, Inc. (RXST) Investors to Inquire About a Securities Fraud Class Action - TradingView
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
RXST Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the RxSight, Inc. Class Action - Morningstar
Will RxSight Inc. outperform the marketLow Exposure Strategy with Sector Analysis - Newser
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
Does RxSight Inc. fit your quant trading modelFree Smart Allocation Stock Pick Insights - Newser
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Morningstar
Shareholders that lost money on RxSight, Inc.(RXST) should contact Levi & Korsinsky about pending Class ActionRXST - Morningstar
The Cost of Deception: Analyzing RxSight's Securities Fraud and Market Impact - AInvest
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
Berger Montague PC Investigates Investor Losses Related to RxSight, Inc. (RXST) Following Class Action Filing - TradingView
RXST LAWSUIT: RxSight, Inc. Sued for Fraud after LDD Sales - GlobeNewswire
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - FinancialContent
Important Notice to Long-Term Shareholders of Alto - GlobeNewswire
RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky to Join Class Action Before September 22, 2025 - TradingView
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds RxSight, Inc. (RXST) Investors of September 22, 2025 Deadline - ACCESS Newswire
RxSight (RXST) and the Risks of Healthcare Tech Volatility: A Deep Dive into Securities Fraud and Operational Collapse - AInvest
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Will RxSight Inc. stock split in the near futureFree Investment Portfolio Suggestions - Newser
Why RxSight Inc. stock attracts strong analyst attentionFree High-Accuracy Stock Picks - Newser
Class Action Filed Against RxSight, Inc. (RXST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Securities Fraud in the Biotech Sector: Evaluating Risks and Governance Gaps at RxSight (RXST) - AInvest
RXST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
RXST STOCK UPDATE: RxSight, Inc. (NASDAQ:RXST) is being - GlobeNewswire
RxSight INVESTOR ALERT: Edelson Lechtzin LLP Urges RxSight, - GlobeNewswire
Corporate Governance Failures and Shareholder Risks at RxSight, Inc. (RXST): A Cautionary Tale for the Medtech Sector - AInvest
DEADLINE ALERT for BHVN, NEOG, and RXST: The Law Offices of - GlobeNewswire
Join Class Action to Recover Losses from RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
Lost Money on RxSight, Inc. (RXST)? Urged to Join Class Action Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
RXST Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against RxSight, Inc. - GlobeNewswire
What drives RxSight Inc. stock priceRapid portfolio appreciation - PrintWeekIndia
RxSight INVESTOR ALERT: Edelson Lechtzin LLP Urges RxSight, Inc. (NASDAQ: RXST) Shareholders With Substantial Losses to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action - GlobeNewswire
Deadline Approaching: RxSight, Inc. (RXST) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith - FinancialContent
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):